(0.29%) 5 114.66 points
(0.31%) 38 358 points
(0.31%) 15 978 points
(-0.91%) $83.09
(5.77%) $2.03
(0.36%) $2 355.70
(0.44%) $27.66
(4.01%) $959.05
(-0.22%) $0.933
(-0.41%) $10.98
(-0.55%) $0.796
(1.69%) $93.43
Live Chart Being Loaded With Signals
Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary...
Stats | |
---|---|
本日の出来高 | 296 322 |
平均出来高 | 594 359 |
時価総額 | 110.18M |
EPS | $-0.280 ( 2021-11-15 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.694 |
ATR14 | $0.0990 (8.92%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-01-24 | Klein Christopher | Sell | 9 605 | Ordinary Shares |
2020-05-20 | Cowan Gregory L | Buy | 38 716 | Ordinary Shares |
2020-05-21 | Cowan Gregory L | Sell | 11 112 | Ordinary Shares |
2020-01-28 | Schaub James | Sell | 9 197 | Ordinary Shares |
2019-01-24 | Weiss Fred G | Buy | 34 403 | Ordinary Shares |
INSIDER POWER |
---|
0.00 |
Last 6 transactions |
Buy: 177 968 | Sell: 29 914 |
ボリューム 相関
Osmotica Pharmaceuticals 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Osmotica Pharmaceuticals 相関 - 通貨/商品
Osmotica Pharmaceuticals 財務諸表
Annual | 2022 |
収益: | $49.72M |
総利益: | $40.27M (80.98 %) |
EPS: | $-0.580 |
FY | 2022 |
収益: | $49.72M |
総利益: | $40.27M (80.98 %) |
EPS: | $-0.580 |
FY | 2020 |
収益: | $177.88M |
総利益: | $103.40M (58.13 %) |
EPS: | $-1.520 |
FY | 2019 |
収益: | $240.03M |
総利益: | $128.40M (53.49 %) |
EPS: | $-5.17 |
Financial Reports:
No articles found.
Osmotica Pharmaceuticals
Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary. The company's promoted products include M-72, a methylphenidate hydrochloride extended-release tablet to treat attention deficit hyperactivity disorder (ADHD); Osmolex ER, an amantadine extended-release tablet for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adults; Arbaclofen extended-release tablets which is in phase III clinical trial for the treatment of multiple sclerosis spasticity; Upneeq, an oxymetazoline hydrochloride ophthalmic solution for the treatment of Blepharoptosis; and OS870 which is in Phase I clinical trial for the treatment of neurodegenerative disorders. It also provides women's health products, including Divigel for menopause; and OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods. In addition, the company's non-promoted products comprise methylphenidate ER tablets for ADHD; venlafaxine ER tablets to treat major depressive disorders and social anxiety disorders; hydromorphone ER for treating pain; nifedipine ER for hypertension; sodium benzoate/sodium phenylacetate for the treatment of hyperammonemia; oxybutynin ER for overactive bladder; prescription prenatal vitamins for treating nutritional requirements during pregnancy; Lorzone, an immediate-release form of chlorzoxazone indicated for the treatment of acute musculoskeletal pain in conjunction with rest and physical therapy; ConZip, a tramadol hydrochloride for the management of pain; and nitrofurantoin for the treatment of urinary tract infections, as well as Osmodex and other abbreviated new drug applications. Osmotica Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。